Alirocumab (anti-PCSK9)

MedChem Express

Alirocumab (anti-PCSK9) [1245916-14-6]

10

Research Use Only

Monoclonal

98.24

Alirocumab (anti-PCSK9) is an anti-PCSK9 human monoclonal antibody. Alirocumab (anti-PCSK9) inhibits PCSK9 . Alirocumab (anti-PCSK9) reduces NLRP3 inflammasome , regulates Nrf2/HO-1 , HMGB1/NF-kappaB and Fractalkine/CX3CR1 . Alirocumab (anti-PCSK9) increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood. Alirocumab (anti-PCSK9) improves atherosclerosis and inflammation [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] .

-80°C

12352203